Announcement:

Register and join online for the fireside chat: Creating a Powerful NAM respiratory Toxicology Strategy for Clinical Predictivity and IND Success on the 17th October 2024

Find out more

Home › Resources › Fact sheets › High throughput, high sensitivity (HTHS) lung fibroblast-to-myofibroblasts transition (FMT) assay for anti-fibrotic drug screening

High throughput, high sensitivity (HTHS) lung fibroblast-to-myofibroblasts transition (FMT) assay for anti-fibrotic drug screening

Published

26th June, 2024

Published by

Newcells Biotech

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download the overview of the Lung FMT assay